Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neal D Ryan

Showing results (171-180 of 179) with videos related to

Pageof 18
Sort By:
You have reached the last page of results.This site can display upto 179 results.
Journal of Affective Disorders|January 8, 2021
Longitudinal course of depressive symptom severity among youths with bipolar disorders: Moderating influences of sustained attention and history of child maltreatmentRachel A Vaughn-Coaxum, John Merranko, Boris Birmaher, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sampleBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The American Journal of Psychiatry|February 19, 2009
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyDavid A Brent, Graham J Emslie, Greg N Clarke, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
European Child & Adolescent Psychiatry|October 7, 2015
Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorderDaniel P Dickstein, David Axelson, Alexandra B Weissman, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Archives of General Psychiatry|March 7, 2002
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disordersDennis S Charney, Charles B Nemeroff, Lydia Lewis, et al.
Pageof 18

Showing results (171-180 of 179) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 179 results.
Journal of Affective Disorders|January 8, 2021
Longitudinal course of depressive symptom severity among youths with bipolar disorders: Moderating influences of sustained attention and history of child maltreatmentRachel A Vaughn-Coaxum, John Merranko, Boris Birmaher, et al.
The Journal of Clinical Psychiatry|January 7, 2011
Long-term outcome of adolescent depression initially resistant to selective serotonin reuptake inhibitor treatment: a follow-up study of the TORDIA sampleBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The Journal of Clinical Psychiatry|September 27, 2019
CorrectionBenedetto Vitiello, Graham Emslie, Gregory Clarke, et al.
The American Journal of Psychiatry|February 19, 2009
Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) studyDavid A Brent, Graham J Emslie, Greg N Clarke, et al.
Archives of General Psychiatry|March 9, 2011
Incremental cost-effectiveness of combined therapy vs medication only for youth with selective serotonin reuptake inhibitor-resistant depression: treatment of SSRI-resistant depression in adolescents trial findingsFrances L Lynch, John F Dickerson, Greg Clarke, et al.
European Child & Adolescent Psychiatry|October 7, 2015
Cognitive flexibility and performance in children and adolescents with threshold and sub-threshold bipolar disorderDaniel P Dickstein, David Axelson, Alexandra B Weissman, et al.
The Journal of Clinical Psychiatry|August 3, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a brief reportRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
The Journal of Clinical Psychiatry|August 28, 2010
Suicidality and risk of suicide--definition, drug safety concerns, and a necessary target for drug development: a consensus statementRoger E Meyer, Carl Salzman, Eric A Youngstrom, et al.
Archives of General Psychiatry|March 7, 2002
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disordersDennis S Charney, Charles B Nemeroff, Lydia Lewis, et al.
Pageof 18